Actavis PLC (NYSE:ACT)

303.56
Delayed Data
As of Mar 27
 +2.24 / +0.74%
Today’s Change
184.71
Today|||52-Week Range
317.72
+17.93%
Year-to-Date

Today’s Trading

Previous close301.32
Today’s open300.91
Day’s range300.64 - 306.17
Volume2,032,448
Average volume (3 months)3,208,051
Market cap$122.9B
Dividend yield--
Data as of 4:03pm ET, 03/27/2015

Growth & Valuation

Earnings growth (last year)-40.80%
Earnings growth (this year)+22.84%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+50.53%
P/E ratioNM
Price/Sales4.33
Price/Book2.85

Competitors

 Today’s
change
Today’s
% change
SNYSanofi+1.17+2.40%
GSKGlaxoSmithKline+0.36+0.77%
NVONovo Nordisk+0.58+1.09%
BMYBristol-Myers Squibb+0.26+0.40%
Data as of 4:03pm ET, 03/27/2015

Financials

Next reporting dateApril 29, 2015
EPS forecast (this quarter)$4.06
Annual revenue (last year)$13.1B
Annual profit (last year)-$1.6B
Net profit margin-12.48%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Brenton L. Saunders
Chief Operating Officer
Robert A. Stewart
Corporate headquarters
Dublin, Dublin

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account